BIOS Health Company Research Report

Company Overview

• Name: BIOS Health

• Mission: To improve people's quality of life through neural engineering by making personalised, precision medicine a reality. BIOS envisions a future where its Neural Digital Therapy technology is being used to give individuals control over their bodies and lives, resulting in radically improved and seamlessly experienced healthcare.

• Founded: 2015

• Founders: Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer.

• Key People:

• Emil Hewage - CEO & Founder

• Oliver Armitage - Chief Scientific Officer & Founder

• Prof. Joanne Hackett - BIOS Board Chair

• Patrick Porritt - Chief Business Officer

• Paul Hughes - Chief Operating Officer

• Headquarters: Cambridge, UK

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Developing AI-driven precision medicine for the nervous system using data-driven insights to build neural digital therapies.

Products

Neural Interfaces and AI Platform

• Description: BIOS has developed neural interfaces and AI that can read and write the body’s neural data to understand and correct faulty neural signals in real time.

• Key Features:

• Real-time insights: Ability to measure and analyze neural data in both acute and chronic settings.

• Neural biomarker discovery: Programming language for the nervous system for groundbreaking insights and treatments.

• Precision health: Creation of neural digital therapeutics using real-time feedback for more targeted drugs and software-delivered therapies.

Autonomic Therapy Initiative (ATI)

• Description: Focuses on the links between the nervous system and cardiovascular diseases, aiming to develop neural therapies and treatments.

Neural Dosing Platform

• Description: Uses high-quality neural recordings with AI and ML techniques to personalize neural therapies.

• Key Features:

• Reduces time on efficacy results from months to minutes.

• Provides automated stimulation setting suggestions.

Modular Platform for Therapy Development

• Description: Flexible platform for neural biomarker discovery and therapy development.

• Key Features:

• Accelerates therapy discovery 15x faster than competitors.

• Offers optimal dosing in less than 10 minutes.

• Provides remote outcome metrics via wearables.

Recent Developments

• New Products Launched:

• No information is available

• New Features Added:

• No information is available

• New Partnerships:

• Partnering with eight top clinics and research centers as part of the SPARC program to create the world's largest dataset of multi-organ responses to bioelectronic stimulation.

• Plans to open a state-of-the-art Precision Medicine Center in Bakersfield, California.

Additional Information

• Media Highlights: BIOS Health has been featured in various publications, highlighting its innovative approach in AI-driven neural therapies.

• Awards:

• Named a top startup by TechCrunch in YC W’17

• Top Healthcare Startup in Europe 2019

• Wired Health EY Startup of the Year 2021

• CogX Best Innovation in Personalised Medicine 2022

For further details or to explore partnership opportunities, contact BIOS at info@bios.health or partnerships@bios.health.